HHealthcare Read More Hospitals launch chatbots, creating another funnel for patient intakeApril 13, 2026 Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
HHealthcare Read More A mother’s 20-year quest fuels a startling Duchenne breakthroughApril 8, 2026 A year after the worst day of her life, Debra Miller received a voicemail she couldn’t quite make…
HHealthcare Read More Insurers, hospitals agree AI scribes raise medical bills. What now?April 8, 2026 To hear health systems tell the story, artificial intelligence tools like ambient scribes are helping not only reduce…
HHealthcare Read More Pharma penalties for doctors’ kickbacks just a cost of doing businessMarch 25, 2026 Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs…
MMedication Read More GOP Sen. Johnson investigating FDA rare disease drug rejectionsMarch 11, 2026 WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
MMedication Read More How Hims has transformed medicine in a few short yearsMarch 10, 2026 As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front…
HHealthcare Read More FDA offers clues to AI regulation with RecovryAI designationMarch 3, 2026 Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
NNutrition Read More Why clinical trials on nutritional supplements are hard to designFebruary 27, 2026 Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
HHealthcare Read More Digital twins in health care: Promising technology still years awayFebruary 24, 2026 Two decades ago, futurist Ray Kurzweil laid out a bold vision for next-generation medicine in his book “The…
MMedication Read More FDA’s Høeg plans to scrutinize SSRIs, RSV shots for babiesFebruary 20, 2026 WASHINGTON — Tracy Beth Høeg, the top drug regulator at the Food and Drug Administration, indicated in her…
BBusiness Read More FDA reverses course, agrees to review Moderna’s flu vaccineFebruary 18, 2026 WASHINGTON — The Food and Drug Administration reversed course and told Moderna it would review its application for…
MMedication Read More We’re reading about China’s GLP-1 drugs, a puzzling FDA rejectionFebruary 18, 2026 Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and rewarding…